These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2534976)

  • 1. Thromboxane A2: its generation and role in platelet activation.
    Arita H; Nakano T; Hanasaki K
    Prog Lipid Res; 1989; 28(4):273-301. PubMed ID: 2534976
    [No Abstract]   [Full Text] [Related]  

  • 2. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
    De Clerck F; Beetens J; de Chaffoy de Courcelles D; Vercammen E; Freyne E; Janssen PA
    Prog Clin Biol Res; 1989; 301():567-72. PubMed ID: 2529556
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case with polycythemia vera, presenting subnormal platelet response to thromboxane A2].
    Yoshioka N; Dohi K; Enomoto Y; Kumada M; Fujii Y; Kagoshima T; Ishikawa H; Sugiyama T; Kanaji K; Okuma M
    Nihon Naika Gakkai Zasshi; 1987 Mar; 76(3):404-8. PubMed ID: 2956344
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of thromboxane receptors in human platelets.
    Jones RL; Wilson NH; Armstrong RA
    Adv Exp Med Biol; 1985; 192():67-81. PubMed ID: 3010674
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different pathways initiating arachidonic acid (AA) release/thromboxane (TxA2) formation in human platelets--studies with fluoride and phorbol ester.
    Lenfers B; Kienast J; van de Loo J
    Prog Clin Biol Res; 1989; 301():309-14. PubMed ID: 2552463
    [No Abstract]   [Full Text] [Related]  

  • 10. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor.
    Mais DE; Halushka PV
    Prog Clin Biol Res; 1989; 301():303-7. PubMed ID: 2529550
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation.
    Heinroth-Hoffmann I; Hauser A; Mest HJ
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):181-2. PubMed ID: 2149184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation by tetraprenol via stimulation of phospholipase A2 action.
    Nakano T; Matsumoto S; Hanasaki K; Arita H
    J Biochem; 1989 Nov; 106(5):887-93. PubMed ID: 2533198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis.
    Laffi G; Cominelli F; La Villa G; Fedi S; Pinzani M; Meacci E; Gentilini P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():366-9. PubMed ID: 2959079
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet thromboxane A2 receptor].
    Ushikubi F; Hirata M; Narumiya S; Okuma M
    Nihon Rinsho; 1992 Feb; 50(2):264-8. PubMed ID: 1535387
    [No Abstract]   [Full Text] [Related]  

  • 16. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets.
    Hanasaki K; Nakano T; Arita H
    Thromb Res; 1987 May; 46(3):425-36. PubMed ID: 2955543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal platelet function, but increased platelet activation in vivo in diabetic patients.
    Tomaselli L; Cerletti C; de Gaetano G; Notarbartolo A; Davì G; Pupillo M
    Thromb Haemost; 1990 Dec; 64(4):604. PubMed ID: 2128141
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity.
    Barradas MA; Jeremy JY; Kontoghiorghes GJ; Mikhailidis DP; Hoffbrand AV; Dandona P
    FEBS Lett; 1989 Mar; 245(1-2):105-9. PubMed ID: 2494068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
    Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA
    J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superoxide dismutase triggers activation of "primed" platelets.
    Iuliano L; Praticò D; Ghiselli A; Bonavita MS; Violi F
    Arch Biochem Biophys; 1991 Aug; 289(1):180-3. PubMed ID: 1910314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.